SE9700566D0 - Modified proteins - Google Patents

Modified proteins

Info

Publication number
SE9700566D0
SE9700566D0 SE9700566A SE9700566A SE9700566D0 SE 9700566 D0 SE9700566 D0 SE 9700566D0 SE 9700566 A SE9700566 A SE 9700566A SE 9700566 A SE9700566 A SE 9700566A SE 9700566 D0 SE9700566 D0 SE 9700566D0
Authority
SE
Sweden
Prior art keywords
receptor
modified proteins
molecule
heterodemeric
hghr
Prior art date
Application number
SE9700566A
Other languages
English (en)
Inventor
Michael Sundstroem
Gunnar Norstedt
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9700566A priority Critical patent/SE9700566D0/sv
Publication of SE9700566D0 publication Critical patent/SE9700566D0/sv
Priority to CA002281032A priority patent/CA2281032A1/en
Priority to PCT/SE1998/000277 priority patent/WO1998035991A1/en
Priority to US09/355,664 priority patent/US6891025B2/en
Priority to AU62356/98A priority patent/AU740901B2/en
Priority to JP53567598A priority patent/JP2001511802A/ja
Priority to NZ337674A priority patent/NZ337674A/xx
Priority to EP98904506A priority patent/EP1005491A1/en
Priority to US10/806,655 priority patent/US20040157298A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/306Extraction; Separation; Purification by precipitation by crystallization
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9700566A 1997-02-18 1997-02-18 Modified proteins SE9700566D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700566A SE9700566D0 (sv) 1997-02-18 1997-02-18 Modified proteins
CA002281032A CA2281032A1 (en) 1997-02-18 1998-02-17 Modified cytokine receptor protein
PCT/SE1998/000277 WO1998035991A1 (en) 1997-02-18 1998-02-17 Modified cytokine receptor protein
US09/355,664 US6891025B2 (en) 1997-02-18 1998-02-17 Modified cytokine receptor protein
AU62356/98A AU740901B2 (en) 1997-02-18 1998-02-17 Modified cytokine receptor protein
JP53567598A JP2001511802A (ja) 1997-02-18 1998-02-17 修飾サイトカインレセプタータンパク質
NZ337674A NZ337674A (en) 1997-02-18 1998-02-17 Modified human growth hormone receptor protein capable of being crystallised
EP98904506A EP1005491A1 (en) 1997-02-18 1998-02-17 Modified cytokine receptor protein
US10/806,655 US20040157298A1 (en) 1997-02-18 2004-03-23 Modified cytokine receptor protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700566A SE9700566D0 (sv) 1997-02-18 1997-02-18 Modified proteins

Publications (1)

Publication Number Publication Date
SE9700566D0 true SE9700566D0 (sv) 1997-02-18

Family

ID=20405835

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700566A SE9700566D0 (sv) 1997-02-18 1997-02-18 Modified proteins

Country Status (8)

Country Link
US (2) US6891025B2 (sv)
EP (1) EP1005491A1 (sv)
JP (1) JP2001511802A (sv)
AU (1) AU740901B2 (sv)
CA (1) CA2281032A1 (sv)
NZ (1) NZ337674A (sv)
SE (1) SE9700566D0 (sv)
WO (1) WO1998035991A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
US20070031926A1 (en) * 2003-12-15 2007-02-08 Lars Linden Refolded membrane protein in monodisperse form
DE60322727D1 (de) * 2003-12-15 2008-09-18 Phasys Gmbh M Rückgefaltetes Membranprotein in monodisperser Form
WO2006001770A1 (en) * 2004-06-28 2006-01-05 Biovitrum Ab Method for identifying modulators of cytokine class i receptor

Also Published As

Publication number Publication date
WO1998035991A1 (en) 1998-08-20
US6891025B2 (en) 2005-05-10
NZ337674A (en) 2001-01-26
US20040157298A1 (en) 2004-08-12
JP2001511802A (ja) 2001-08-14
CA2281032A1 (en) 1998-08-20
AU6235698A (en) 1998-09-08
AU740901B2 (en) 2001-11-15
US20030009009A1 (en) 2003-01-09
EP1005491A1 (en) 2000-06-07

Similar Documents

Publication Publication Date Title
ATE187982T1 (de) Cytokine antagoniste
PT1066380E (pt) Receptor de celula t soluvel
DK0760857T3 (da) Receptor for onkostatin M
DK0584082T3 (da) Domæner i den ekstracellulære region af humane blodpladeafledte vækstfaktorreceptorpolypeptider
NO991162D0 (no) Monoklonale antistoffer mot det ekstracellulµre domene av humant VEGF-reseptorprotein (KDR)
BR9508985A (pt) Ligantes de receptores x de ácido retinóico
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
DE69428536T2 (de) A3 -adenosin -rezeptor agonisten
HUP0100436A2 (hu) Emlős citokinszerű polipeptid-10
DE59911879D1 (de) Verwendung von biogenen estrogensulfamaten zur hormonsubstitutionstherapie
DK0613499T3 (da) Humame IT-4-mutantproteiner
DE69314024D1 (de) NEUE GABAa-REZEPTORSUBTYPEN UND VERFAHREN ZUM SCREENING VON ARZNEIMITTELVERBINDUNGEN UNTER VERWENDUNG VON GABAa-REZEPTORSUBTYPEN BINDENDE IMIDAZOCHINOXALINE UND PYRROLOPYRIMIDINE
SE9700566D0 (sv) Modified proteins
BR9815335A (pt) Uso de antagonistas de receptor de endotelina.
AU7078200A (en) Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use
ATE271394T1 (de) Hybride zusammensetzungen für intrazellulaire verabreichung
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
WO2002007676A3 (en) Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr)
DE69838838D1 (de) Lactoferrinrezeptorgen von moraxella
ES2172939T3 (es) Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores.
DE69927375D1 (de) Fusionsprotein mit direkter verknüpfung des il-6-rezeptors mit il-6
ATE217619T1 (de) Endothelin-rezeptor-antagonisten
NO993548D0 (no) Anvendelse av <beta>3-adrenergiske reseptoragonister for fremstilling av legende medikamenter
DE59813016D1 (de) Cadherin derived growth factor und seine verwendung
EE200900055A (et) TNF/NFG retseptoriperekonna retseptorite ja muude valkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon